Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The significance of subdivisions of microscopically positive (R1) margins in colorectal cancer: A retrospective study of a national cancer registry

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Collaboration in colorectal surgical research

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Predicting life with a permanent end colostomy: A prospective study on function, bother and acceptance

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Stoma-related complications: a report from the Stoma-Const randomized controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Impact of the COVID-19 pandemic on the management of colorectal cancer in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

AIM: Microscopically positive (R1) margins are associated with poorer outcomes in patients with colorectal cancer. However, little is known of the differential impact of subdivisions of R1 margins, be they to the primary tumour (R1tumour) or to lymph node metastases/tumour deposits (R1LNM).

METHODS: Patients treated for Stage III colorectal cancer from 1 January 2016 to 31 December 2019 were identified from the Danish national cancer registry. Patients were stratified into three groups according to margin status (R0 vs. R1tumour vs. R1LNM). The primary outcome was overall survival.

RESULTS: In all, 4186 patients were included, comprising 3012 patients with colon cancer and 1174 patients with rectal cancer. The R1 resection rates were 16.5% and 18.2% in patients with colon and rectum cancer, respectively. In colon cancers, 3-year overall survival was reduced in patients with R1LNM (65.7%, 95% CI 62.8-68.6) or R1tumour margins (51.8%, 95% CI 47.3-56.3) compared with R0 resections (80.8%, 95% CI 79.9-81.6, P < 0.001). A similar impact on survival was seen in rectal cancers (R0, 84.2%, 95% CI 82.9-85.5; R1LNM, 72.2%, 95% CI 67.8-76.6; R1tumour, 56.6%, 95% CI 50.0-63.2, P < 0.001). Margin status was independently prognostic of survival in both colon (R1tumour, hazard ratio 2.08, 95% CI 1.50-2.89, P < 0.001; R1LNM, hazard ratio 1.48, 95% CI 1.11-1.97, P = 0.008) and rectal cancers (R1tumour, hazard ratio 2.35, 95% CI 1.42-3.90, P < 0.001; R1LNM, hazard ratio 1.54, 95% CI 0.95-2.48, P = 0.077).

CONCLUSION: R1 subdivisions have distinct impacts on survival in Stage III colorectal cancer. Further focused research in these patient subgroups is warranted.

OriginalsprogEngelsk
TidsskriftColorectal Disease
Vol/bind24
Udgave nummer2
Sider (fra-til)197-209
Antal sider13
ISSN1462-8910
DOI
StatusUdgivet - feb. 2022

Bibliografisk note

© 2021 The Association of Coloproctology of Great Britain and Ireland.

ID: 74912609